
Our team comprises seasoned scientists with extensive backgrounds in autism preclinical studies. This experience allows us to design and implement robust experimental frameworks tailored to your research needs, ensuring reliable results.
We uphold rigorous quality standards in all our services, adhering to GLP principles to ensure scientific rigor. Our AAALAC accreditation further validates our commitment to maintaining the highest quality in autism preclinical research.
KCI Biotech offers tailored solutions to meet specific project requirements. Our flexible approach enables us to adapt methodologies and plans according to diverse needs, facilitating successful partnerships in autism studies.
From study design to reporting, we provide full-spectrum support throughout your research project. Our dedicated team ensures effective communication and collaboration, enhancing the efficiency of autism preclinical drug development.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china